🔗 Share this article

Chancellor Reeves has announced she is planning "specific action to tackle cost of living issues" in the forthcoming financial statement.

Speaking to media outlets, she stated that curbing price rises is a collective task of both the government and the central bank.

The UK's price growth is projected to be the highest among the Group of Seven advanced economies this year and the following year.

Potential Utility Bill Measures

Reports indicate the government could intervene to lower energy bills, such as by reducing the present 5% level of value-added tax applied on energy.

Another option is to lower some of the government charges presently included in bills.

Fiscal Constraints and Analyst Predictions

The government will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much space there is for such measures.

The view from most analysts is that Reeves will have to announce higher taxes or budget cuts in order to meet her voluntary fiscal targets.

Previously on Thursday, analysis suggested there was a £22 billion gap for the Treasury chief to fill, which is at the more modest range of projections.

"It is a collective responsibility between the Bank of England and the government to continue tackling some of the drivers of price increases," the Chancellor stated to reporters in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Commitments and Global Issues

While a great deal of the attention has been on expected tax rises, the Treasury chief said the most recent data from the OBR had not altered her pledge to election pledges not to raise tax levels on earnings tax, sales tax or National Insurance.

She blamed an "uncertain world" with growing geopolitical and commercial issues for the Budget revenue measures, probably to be targeted on those "with the broadest shoulders."

Global Economic Tensions

Addressing apprehensions about the UK's trade ties with the Asian nation she said: "Our security interests always take priority."

Last week's announcement by China to increase export controls on critical minerals and other resources that are essential for advanced tech production led American leader the US President to propose an extra 100% import tax on imports from the Asian country, raising the prospect of an full-scale trade war between the two global powers.

The US Treasury Secretary described the Chinese action "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the American proposal to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by China's actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "harmful for the world economy and creates further headwinds."

"I believe there are fields where we should confront Chinese policies, but there are also significant opportunities to export to China's economy, including financial services and other areas of the economy. We've got to achieve that balance right."

The chancellor also affirmed she was collaborating with international partners "regarding our own critical minerals strategy, so that we are less reliant."

Health Service Drug Pricing and Investment

The Chancellor also recognized that the price the NHS pays for drugs could increase as a result of ongoing talks with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or canceling operations in the United Kingdom, with several blaming the insufficient payments they are obtaining.

Recently, the government science advisor said the price the health service spends on drugs would need to go up to halt firms and drug research funding departing from the United Kingdom.

The Chancellor stated to the BBC: "It has been observed due to the pricing regime, that drug testing, new drugs have not been available in the UK in the way that they are in other European countries."

"The objective is to ensure that patients getting treatment from the National Health Service are able to obtain the top critical treatments in the globe. And so we are reviewing these issues, and... looking to secure additional capital into the UK."